Fundamental Valuation Report Karuna Therapeutics(KRTX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$107.55 (USD) 05/05/2021 Weighted Valuation$93.49 (USD) Overall RatingOvervalued by 13.1% Valuation Models Adjusted Book Value: $90.58 (USD) …

Karuna Therapeutics (KRTX:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Leaf Group(LEAF:NYS) Communication Services:Internet Content & Information This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.72 (USD) 05/05/2021 Weighted Valuation$6.17 (USD) Overall RatingOvervalued by 29.3% Valuation Models …

Leaf Group (LEAF:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report LGI Homes(LGIH:NAS) Consumer Cyclical:Residential Construction This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$172.11 (USD) 05/05/2021 Weighted Valuation$141.00 (USD) Overall RatingOvervalued by 18.1% Valuation Models Comparables: $82.65 (USD) …

LGI Homes (LGIH:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Kinsale Capital Gr(KNSL:NAS) Financial Services:Insurance – Property & Casualty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$170.09 (USD) 05/04/2021 Weighted Valuation$136.85 (USD) Overall RatingOvervalued by 19.5% …

Kinsale Capital Gr (KNSL:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report DocuSign(DOCU:NAS) Technology:Software – Application This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$215.10 (USD) 05/03/2021 Weighted Valuation$183.90 (USD) Overall RatingOvervalued by 14.5% Valuation Models Comparables: $144.47 (USD) Multiples: $122.24 …

DocuSign (DOCU:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report RH(RH:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$699.05 (USD) 05/03/2021 Weighted Valuation$350.78 (USD) Overall RatingOvervalued by 49.8% Valuation Models Comparables: $205.69 (USD) (in …

RH (RH:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report GameStop(GME:NYS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$162.20 (USD) 05/03/2021 Weighted Valuation$83.48 (USD) Overall RatingOvervalued by 48.5% Valuation Models Comparables: $83.48 (USD) Valuation …

GameStop (GME:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Insmed(INSM:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$33.73 (USD) 04/30/2021 Weighted Valuation$31.94 (USD) Overall RatingOvervalued by 5.3% Valuation Models Comparables: $24.58 (USD) (in order of …

Insmed (INSM:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Iovance Biotherapeutics(IOVA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.44 (USD) 04/30/2021 Weighted Valuation$28.57 (USD) Overall RatingOvervalued by 9.1% Valuation Models Comparables: $26.70 (USD) (in order …

Iovance Biotherapeutics (IOVA:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Intra-Cellular Therapies(ITCI:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$34.43 (USD) 04/30/2021 Weighted Valuation$26.38 (USD) Overall RatingOvervalued by 23.4% Valuation Models Comparables: $26.38 (USD) Valuation Methods …

Intra-Cellular Therapies (ITCI:NAS) Fundamental Valuation Report Read more »

Read More